https://biotechmorning.com/news/astrazeneca-ionis-attr-cm-phase-3-failure Biotech Morning en 2026-08-03T14:24:07.244Z The $30 Billion Wipeout That Started With a Bad Test Design https://biotechmorning.com/news/jj-sail-biomedicines-in-vivo-car-t-deal Biotech Morning en 2026-08-03T14:23:10.235Z J&J Just Put $2.58 Billion on a CAR-T Therapy That Doesn't Exist Yet https://biotechmorning.com/news/astrazeneca-bms-megamerger-talks Biotech Morning en 2026-08-03T14:22:16.211Z The $400 Billion Pharma Marriage Nobody Asked For https://biotechmorning.com/news/weight-loss-drug-aced-alcohol-addiction-trial Biotech Morning en 2026-08-03T14:21:24.289Z A Weight-Loss Drug Just Aced an Alcohol Addiction Trial https://biotechmorning.com/news/moderna-mrna-flu-vaccine-fda-decision Biotech Morning en 2026-08-03T14:20:33.247Z The Flu Shot Hasn't Changed in Decades. That Might End Tuesday. https://biotechmorning.com/news/arpa-h-160-million-gene-editing-thrive-program Biotech Morning en 2026-08-03T14:19:40.505Z The $160 Million Bet That Could Turn One-Patient Miracles Into a Playbook https://biotechmorning.com/news/replimune-rp1-fda-rejection-melanoma-stock-crash Biotech Morning en 2026-08-03T14:18:50.013Z The Virus That Couldn't Catch a Break https://biotechmorning.com/news/elevidys-gene-therapy-liver-failure-deaths-fda-investigation Biotech Morning en 2026-08-03T14:17:55.195Z The Gene Therapy That Saved Kids' Muscles May Be Destroying Their Livers https://biotechmorning.com/news/fda-oncology-trial-eligibility-guidances-2026 Biotech Morning en 2026-08-02T14:22:47.501Z The FDA Just Blew Open the Doors to Cancer Clinical Trials https://biotechmorning.com/news/tepezza-lost-monopoly-viridian-lumvoa-approval Biotech Morning en 2026-08-02T14:22:02.546Z Tepezza Just Lost Its $1.9 Billion Monopoly https://biotechmorning.com/news/one-dose-lsd-beat-every-antidepressant Biotech Morning en 2026-08-02T14:21:05.985Z One Dose of LSD Just Beat Every Antidepressant on the Market https://biotechmorning.com/news/lilly-abbisko-china-oncology-deal Biotech Morning en 2026-08-02T14:20:14.082Z Lilly Just Bet $1.9B on a Shanghai Biotech. In This Political Climate. https://biotechmorning.com/news/lantheus-cancer-imaging-fda-manufacturing-rejection Biotech Morning en 2026-08-02T14:19:20.907Z Lantheus Built a Better Cancer Scanner. The Factory Couldn't Keep Up. https://biotechmorning.com/news/ebola-bundibugyo-strain-vaccine-race Biotech Morning en 2026-08-02T14:18:40.616Z The Ebola Strain Nobody Had a Vaccine For Just Became a Global Emergency https://biotechmorning.com/news/fda-shaved-year-off-drug-timeline Biotech Morning en 2026-08-02T14:17:52.796Z The FDA Just Shaved a Year Off Your Drug's Timeline https://biotechmorning.com/news/fda-real-time-clinical-trial-monitoring-pilot Biotech Morning en 2026-08-02T14:16:57.406Z The FDA Wants to Watch Your Clinical Trial Live. Yes, Really. https://biotechmorning.com/news/oruka-one-shot-psoriasis-beats-skyrizi Biotech Morning en 2026-08-02T14:16:05.237Z One Shot a Year: The Tiny Biotech That Just Embarrassed AbbVie's $18B Drug https://biotechmorning.com/news/intellia-crispr-phase-3-fda-filing Biotech Morning en 2026-08-02T14:15:13.846Z One Shot to Edit Your DNA Forever. The FDA Might Say Yes.